Study design (if review, criteria of inclusion for studies)
Randomised controlled trial. Parallel design.
Participants
20 participants, of which 16 completed. Ages: 5-24 years. CCPT: Mean (range) 10 years (5-18 years); IPV: 12 years (5-24 years).
Interventions
CCPT versus IPV.
Outcome measures
FVC, FEV1, FEF25-75, BMI, patient log/preference, hospital admissions, intravenous antibiotic courses
Main results
No significant differences in spirometric measures, numbers of hospitalizations, use of oral or IV antibiotics, or anthropometric measurements were detected between the standard aerosol/chest physiotherapy group and the IPV group over the duration of the trial. Patient acceptance, as determined by participant survey, was good. The device appeared to be safe and durable.
Authors' conclusions
the IPV is as effective as standard aerosol and chest physiotherapy in preserving lung function and anthropometric measures, and there was no difference in the use of antibiotics and hospitalizations.